Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says

Pfizer (PFE) CEO Albert Bourla is betting massive on repeating the accomplishment of its COVID-19 vaccine with an experimental oral remedy — and he is putting the firm’s money wherever its mouth is.

Bourla explained to Yahoo Finance Wednesday the firm is committing $1 billion to build the oral remedy — a protease inhibitor — which would give the world an uncomplicated-to-use, focused remedy, ideally by year’s stop.

The latest sector for COVID-19 remedies features monoclonal antibodies and some repurposed medications, which include generics and Gilead Sciences’ (GILD) Veklury (previously Remdesivir) – all of which require currently being in a

Read more

Inflatable dinghies and Zoom health care education: how a distant Pacific atoll got Pfizer | Vaccines and immunisation

The elders of Nukunonu atoll in Tokelau at the wharf on Monday early morning, dressed in white and singing tracks, held a banner that reported: “Welcome”.

In the distance, a smaller inflatable boat manufactured its way to them carrying a New Zealand defence officer dressed in entire protecting equipment and 12 cherished containers. Inside the containers ended up just more than 700 doses of Pfizer vaccine, adequate to go over the 346 people of Nukunono who are suitable for the vaccine.

“I am relieved and elated. It is mind-boggling as properly,” claimed Aukusitino Vitale, the chair of the Tokelau countrywide

Read more